Is cbdMD going out of business?

cbdMD, Inc. (YCBD) Fundamentals

A quick summary of the latest filed figures while the full analysis loads.

cbdMD, Inc. (YCBD) scores 16 out of 100 on fundamentals, Distressed / Caution, based on SEC filing data.

Leading signal: Shares dilution YoY: 321.53% (YoY) - Heavy dilution suggests continuous equity raises; survival depends on external capital.

Five questions, kept separate

Survival - Fragile

13-18 mo of estimated runway from 2026-06-30, based on $2.1M of cash and short-term investments against $1.6M of annual burn. A disclosed filing event caps this reading; Event Risk carries the detail.

Business quality - Poor

-11.3% operating margin and -8.5% FCF margin produce a poor Business Quality assessment.

Trajectory - Deteriorating

Revenue expanded while both operating and cash margins deteriorated. Revenue improved 10.0%; operating margin weakened 4.4pp; FCF margin weakened 11.7pp. The TTM window includes a mixed-basis Q4 estimate.

Valuation - Extreme expectations

-30.3% normalized FCF yield supports an extreme expectations Valuation assessment on the annual basis.

Event risk - Critical event risk

Going-Concern Warning is the decisive filing event; one adverse event family is active. It appears across 3 scanned filings. Favorable events are shown separately and do not offset adverse risk.

What the rules read

• Shares dilution YoY: 321.53% (YoY) - Heavy dilution suggests continuous equity raises; survival depends on external capital.
• Debt / Equity: No financial debt (debt-free)
• ROE quality: -24.85%
• ROIC: -28.12%
• Filing event risk: Going-Concern Warning (-8 pts)
• FCF margin: -8.53%
• Asset Efficiency: 1.46x
• Revenue CAGR (3Y): -18.46%
• Gross margin (industrial): 62.37%
• Revenue growth YoY: 20.56% (Industrial YoY) - Growth from a low base; sustainability uncertain.
• Return on Assets: -15.53%
• Net income trend: -25.91%

Read from filings through 2026-09-02.

Price as of 2026-09-11.